<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chemotherapeutic agents (CT) and ionizing radiation (X-ray) induce DNA damage and primarily aim to stop the proliferation of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells </plain></SENT>
<SENT sid="1" pm="."><plain>However, multimodal anti-<z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> therapies should finally result in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell <z:hpo ids='HP_0011420'>death</z:hpo> and, best, in the induction of systemic anti-<z:e sem="disease" ids="C1519680" disease_type="Disease or Syndrome" abbrv="">tumor immunity</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Since distinct therapy-induced <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cell <z:hpo ids='HP_0011420'>death</z:hpo> forms may create an immune activating <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> microenvironment, this study examined whether sole treatment with CT that are used in the therapy for <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> or in combination with X-ray result in <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> cell <z:hpo ids='HP_0011420'>death</z:hpo> with immunogenic potential </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="46345">5-Fluorouracil</z:chebi> (5-FU), <z:chebi fb="0" ids="31941">Oxaliplatin</z:chebi> (Oxp), or Irinotecan (Irino) in combination with X-ray were <z:hpo ids='HP_0000001'>all</z:hpo> potent inhibitors of <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> cell colony formation </plain></SENT>
<SENT sid="4" pm="."><plain>This study then examined the forms of cell <z:hpo ids='HP_0011420'>death</z:hpo> with AnnexinA5-<z:chebi fb="0" ids="37926">FITC</z:chebi>/<z:chebi fb="0" ids="51240">Propidium Iodide</z:chebi> staining </plain></SENT>
<SENT sid="5" pm="."><plain><z:mp ids='MP_0001651'>Necrosis</z:mp> was the prominent form of cell <z:hpo ids='HP_0011420'>death</z:hpo> induced by CT and/or X-ray </plain></SENT>
<SENT sid="6" pm="."><plain>While only a combination of Irino with X-ray leads to <z:hpo ids='HP_0011420'>death</z:hpo> induction already 1 day after treatment, also the combinations of Oxp or 5-FU with X-ray and X-ray alone resulted in high <z:mp ids='MP_0001651'>necrosis</z:mp> rates at later time points after treatment </plain></SENT>
<SENT sid="7" pm="."><plain>Inhibition of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> increased the amount of <z:e sem="disease" ids="C1300818" disease_type="Neoplastic Process" abbrv="">necrotic tumor</z:e> cells, suggesting that a programmed form of <z:mp ids='MP_0001651'>necrosis</z:mp> can be induced by CT + X-ray </plain></SENT>
<SENT sid="8" pm="."><plain>5-FU and Oxp alone or in combination with X-ray and Irino plus X-ray were most effective in increasing the expression of RIP, IRF-5, and p53, proteins involved in necrotic and apoptotic cell <z:hpo ids='HP_0011420'>death</z:hpo> pathways </plain></SENT>
<SENT sid="9" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> treatments further resulted in the release of the immune activating danger signals high-mobility group box 1 (HMGB1) and heat shock protein 70 (HSP70) </plain></SENT>
<SENT sid="10" pm="."><plain>The supernatants of the treated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells induced maturation of dendritic cells </plain></SENT>
<SENT sid="11" pm="."><plain>It is, therefore, concluded that combination of CT with X-ray is capable of inducing in vitro cell <z:hpo ids='HP_0011420'>death</z:hpo> forms of <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumors</z:e> with immunogenic potential </plain></SENT>
</text></document>